You just read:

Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China

News provided by

Regeneron Pharmaceuticals, Inc.

Nov 28, 2011, 02:00 EST